ResMed (RMD) Misses Q1 EPS by 2c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $191.26 +1.49%
EPS Growth %: +13.3%
Financial Fact:
Basic earnings per share: 0.54
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +13.3%
Financial Fact:
Basic earnings per share: 0.54
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.62, $0.02 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $465.4 million versus the consensus estimate of $474.73 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
- This digital health stock is ready to re-rate higher: Goldman
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
